Search the Appendices of Resolution CM/Res(2018)1
1961 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
ELOTUZUMAB | L01FX08 | SI | Not authorised | 30-05-2025 | VALID | |||
MOGAMULIZUMAB | L01FX09 | SI | POM | 30-05-2025 | VALID | |||
OLARATUMAB | L01FX10 | SI | Not authorised | 30-05-2025 | VALID | |||
POLATUZUMAB VEDOTIN | L01FX14 | SI | POM | 30-05-2025 | VALID | |||
SACITUZUMAB GOVITECAN | L01FX17 | SI | POM | 30-05-2025 | VALID | |||
AMIVANTAMAB | L01FX18 | SI | POM | 30-05-2025 | VALID | |||
TREMELIMUMAB | L01FX20 | SI | POM | 30-05-2025 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | SI | POM | 30-05-2025 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
MIRVETUXIMAB SORAVTANSINE | L01FX26 | SI | POM | 30-05-2025 | EMEA/H/C/005036 | 14-11-2024 | VALID | |
GLOFITAMAB | L01FX28 | SI | POM | 30-05-2025 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
TALQUETAMAB | L01FX29 | SI | POM | 30-05-2025 | VALID | |||
ZOLBETUXIMAB | L01FX31 | SI | POM | 30-05-2025 | EMEA/H/C/005868 | 19-09-2024 | VALID | |
ELRANATAMAB | L01FX32 | SI | POM | 30-05-2025 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
PERTUZUMAB AND TRASTUZUMAB | L01FY01 | SI | POM | 30-05-2025 | VALID | |||
NIVOLUMAB AND RELATLIMAB | L01FY02 | SI | POM | 30-05-2025 | VALID | |||
CARBOPLATIN | L01XA02 | SI | POM | 30-05-2025 | None | VALID | ||
TRASTUZUMAB | L01XC03 | SI | Not authorised | 30-05-2025 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
CETUXIMAB | L01XC06 | SI | Not authorised | 30-05-2025 | VALID | |||
BORTEZOMIB | L01XG01 | SI | POM | 30-05-2025 | VALID | |||
CARFILZOMIB | L01XG02 | SI | POM | 30-05-2025 | VALID | |||
VISMODEGIB | L01XJ01 | SI | POM | 30-05-2025 | VALID | |||
OLAPARIB | L01XK01 | SI | POM | 30-05-2025 | VALID | |||
TALAZOPARIB | L01XK04 | SI | POM | 30-05-2025 | VALID | |||
TALIMOGENE LAHERPAREPVEC | L01XL02 | SI | POM | 30-05-2025 | VALID | |||
TABELECLEUCEL | L01XL09 | SI | Not authorised | 30-05-2025 | EMEA/H/C/004577 | 16-12-2022 | VALID | |
IVOSIDENIB | L01XM02 | SI | POM | 30-05-2025 | EMEA/H/C/005936 | 04-05-2023 | VALID | |
HYDROXYCARBAMIDE | L01XX05 | SI | POM | 30-05-2025 | VALID | |||
PEGASPARGASE | L01XX24 | SI | POM | 30-05-2025 | VALID | |||
ARSENIC TRIOXIDE | L01XX27 | SI | POM | 30-05-2025 | VALID | |||
ANAGRELIDE | L01XX35 | SI | POM | 30-05-2025 | 5363-I-539/05 | 20-07-2005 | VALID | |
ERIBULIN | L01XX41 | SI | POM | 30-05-2025 | None | VALID | ||
AFLIBERCEPT | L01XX44 | SI | POM | 30-05-2025 | VALID | |||
ADAGRASIB | L01XX77 | SI | Not authorised | 30-05-2025 | EMEA/H/C/006013 | 05-01-2024 | VALID | |
IMETELSTAT | L01XX80 | SI | POM | 30-05-2025 | EMEA/H/C/006105 | 07-03-2025 | VALID | |
MEGESTROL | L02AB01 | SI | I | 30-05-2025 | 5363-I-452/05 | 14-06-2005 | VALID | |
MEDROXYPROGESTERONE | L02AB02 | SI | Not authorised | 30-05-2025 | VALID | |||
LEUPRORELIN | L02AE02 | SI | POM | 30-05-2025 | 5363-I-618/05 | 23-08-2005 | VALID | |
TAMOXIFEN | L02BA01 | SI | POM | 30-05-2025 | 5363-I-18/04 | 15-01-2004 | VALID | |
FULVESTRANT | L02BA03 | SI | POM | 30-05-2025 | VALID | |||
FLUTAMIDE | L02BB01 | SI | Not authorised | 30-05-2025 | 5363-I-326/02 | 04-07-2002 | VALID | |
ENZALUTAMIDE | L02BB04 | SI | POM | 30-05-2025 | None | VALID | ||
APALUTAMIDE | L02BB05 | SI | POM | 30-05-2025 | VALID | |||
ANASTROZOLE | L02BG03 | SI | I | 30-05-2025 | 5363-I-517/03 | 15-07-2003 | VALID | |
LETROZOLE | L02BG04 | SI | I | 30-05-2025 | 5363-I-213/03 | 18-07-2003 | VALID | |
EXEMESTANE | L02BG06 | SI | I | 30-05-2025 | 512/B-443/01 | 10-12-2001 | VALID | |
ABARELIX | L02BX01 | SI | Not authorised | 30-05-2025 | VALID | |||
ABIRATERONE | L02BX03 | SI | POM | 30-05-2025 | VALID | |||
FILGRASTIM | L03AA02 | SI | POM | 30-05-2025 | VALID | |||
PEGFILGRASTIM | L03AA13 | SI | POM | 30-05-2025 | VALID | |||
LIPEGFILGRASTIM | L03AA14 | SI | POM | 30-05-2025 | VALID |